Yang Chen, Cao Peng, Gao Yang, Wu Ming, Lin Yun, Tian Ye, Yuan Wen
Department of orthopedic Surgery, Changzheng Hospital, Shanghai 200003, China.
Kidney Institute, Department of Nephrology, Changzheng Hospital, Shanghai 200003, China.
Sci Rep. 2016 Feb 25;6:22182. doi: 10.1038/srep22182.
P38MAPK mediates cytokine induced inflammation in nucleus pulposus (NP) cells and involves in multiple cellular processes which are related to intervertebral disc degeneration (IDD). The aim of this study was to investigate the expression, activation and function of p38 MAPK isoforms (α,β, γ and δ) in degenerative NP and the effect of p38 activation in NP cells on macrophage polarization. P38 α, β and δ isoforms are preferential expressed, whereas the p38γ isoform is absent in human NP tissue. LV-sh-p38α, sh-p38β transfection in NP cells significantly decreased the ADAMTS-4,-5, MMP-13,CCL3 expression and restored collagen-II and aggrecan expression upon IL-1β stimulation. As compared with p38α and p38β, p38δ exhibited an opposite effect on ADAMTS-4,-5, MMP-13 and aggrecan expression in NP cells. Furthermore, the production of GM-CSF and IFNγ which were trigged by p38α or p38β in NP cells induced macrophage polarization into M1 phenotype. Our finding indicates that p38 MAPK α, β and δ isoform are predominantly expressed and activated in IDD. P38 positive NP cells modulate macrophage polarization through the production of GM-CSF and IFNγ. Hence, Our study suggests that selectively targeting p38 isoforms could ameliorate the inflammation in IDD and regard IDD progression.
P38丝裂原活化蛋白激酶介导细胞因子诱导的髓核(NP)细胞炎症,并参与与椎间盘退变(IDD)相关的多个细胞过程。本研究的目的是探讨p38丝裂原活化蛋白激酶亚型(α、β、γ和δ)在退变NP中的表达、激活和功能,以及NP细胞中p38激活对巨噬细胞极化的影响。P38α、β和δ亚型在人NP组织中优先表达,而p38γ亚型缺失。在NP细胞中进行LV-sh-p38α、sh-p38β转染可显著降低ADAMTS-4、-5、MMP-13、CCL3的表达,并在IL-1β刺激后恢复胶原蛋白-II和聚集蛋白聚糖的表达。与p38α和p38β相比,p38δ对NP细胞中ADAMTS-4、-5、MMP-13和聚集蛋白聚糖的表达具有相反的作用。此外,NP细胞中由p38α或p38β触发产生的GM-CSF和IFNγ可诱导巨噬细胞极化为M1表型。我们的研究结果表明,p38丝裂原活化蛋白激酶α、β和δ亚型在IDD中主要表达并被激活。P38阳性NP细胞通过产生GM-CSF和IFNγ调节巨噬细胞极化。因此,我们的研究表明,选择性靶向p38亚型可以改善IDD中的炎症并延缓IDD进展。